Last summer, the media was abuzz with apparent progress in developing a reliable blood test for Alzheimer’s disease. With this potential breakthrough—after decades of research to find a biomarker that could clearly diagnosis Alzheimer’s—researchers now may finally have a tool for measuring the effectiveness of drugs and other treatment interventions.